| __timestamp | Alkermes plc | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 447875000 | 179279000 |
| Thursday, January 1, 2015 | 483393000 | 186359000 |
| Friday, January 1, 2016 | 519270000 | 171785000 |
| Sunday, January 1, 2017 | 567637000 | 208136000 |
| Monday, January 1, 2018 | 601826000 | 198405000 |
| Tuesday, January 1, 2019 | 693218000 | 224169000 |
| Wednesday, January 1, 2020 | 572904000 | 245044000 |
| Friday, January 1, 2021 | 603913000 | 252314000 |
| Saturday, January 1, 2022 | 218108000 | 268225000 |
| Sunday, January 1, 2023 | 253037000 | 304629000 |
| Monday, January 1, 2024 | 245331000 | 324203000 |
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis compares the cost of revenue for Alkermes plc and Taro Pharmaceutical Industries Ltd. from 2014 to 2023. Over this period, Alkermes plc experienced a significant fluctuation, peaking in 2019 with a 39% increase from 2014, before dropping sharply by 63% in 2022. Meanwhile, Taro Pharmaceutical Industries Ltd. showed a steady upward trend, culminating in a 70% rise by 2023 compared to 2014. This divergence highlights the contrasting operational strategies and market conditions faced by these companies. Notably, the data for Alkermes plc in 2024 is missing, suggesting potential reporting delays or strategic shifts. As the pharmaceutical landscape continues to shift, these insights offer a glimpse into the financial health and strategic priorities of these industry players.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Amgen Inc. and Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Alkermes plc
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Catalent, Inc. and Alkermes plc's Expenses
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Alkermes plc vs Xenon Pharmaceuticals Inc.
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: HUTCHMED (China) Limited and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Mesoblast Limited and Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. vs Galapagos NV: Efficiency in Cost of Revenue Explored